Edgewise Therapeutics Inc (EWTX)
32.33
+0.35
(+1.09%)
USD |
NASDAQ |
Nov 22, 13:58
Edgewise Therapeutics Total Assets (Quarterly): 511.28M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 511.28M |
| June 30, 2024 | 531.65M |
| March 31, 2024 | 553.81M |
| December 31, 2023 | 340.04M |
| September 30, 2023 | 311.36M |
| June 30, 2023 | 330.62M |
| March 31, 2023 | 346.40M |
| December 31, 2022 | 367.10M |
| Date | Value |
|---|---|
| September 30, 2022 | 377.15M |
| June 30, 2022 | 257.40M |
| March 31, 2022 | 272.74M |
| December 31, 2021 | 285.23M |
| September 30, 2021 | 294.45M |
| June 30, 2021 | 303.49M |
| March 31, 2021 | 311.24M |
| December 31, 2020 | 131.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
131.14M
Minimum
Dec 2020
553.81M
Maximum
Mar 2024
345.32M
Average
320.99M
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 772.01M |
| Cytokinetics Inc | 1.436B |
| Vanda Pharmaceuticals Inc | 645.12M |
| Vertex Pharmaceuticals Inc | 22.24B |
| Sarepta Therapeutics Inc | 3.600B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.40M |
| Shareholders Equity (Quarterly) | 488.88M |